AcquisitionOther
ReShape Lifesciences acquired Vyome Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
ReShape Lifesciences -> Vyome Therapeutics · $400,000
Promissory note for working capital and merger-related expenses rather than acquisition.
Open source record (SEC) ↗